Harvest Fund Management Co., LTD Amgen Inc Transaction History

Harvest Fund Management Co., LTD

$1.66 Billion
Q3 2024

A detailed history of Harvest Fund Management Co., LTD transactions in Amgen Inc stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 27,496 shares of AMGN stock, worth $7.27 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

27,496

Previous 18,972 44.93%

Holding current value

$7.27 Million

Previous $5.93 Million 49.47%

% of portfolio

0.53%

Previous 0.43%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $2.64 Million - $2.88 Million	8,524 Added 44.93%	27,496 $8.86 Million
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $730,970 - $888,320	2,782 Added 17.18%	18,972 $5.93 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $2.65 Million - $3.2 Million	9,862 Added 155.85%	16,190 $4.6 Million
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $447,730 - $505,093	-1,751 Reduced 21.67%	6,328 $1.82 Million
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $973,648 - $1.21 Million	4,453 Added 122.81%	8,079 $2.17 Million
Q2 2023 Jul 07, 2023	SELL	$214.27 - $253.37 $330,832 - $391,203	-1,544 Reduced 29.86%	3,626 $805,000
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $174,309 - $212,454	-772 Reduced 12.99%	5,170 $1.25 Million
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $863,214 - $1.1 Million	3,769 Added 173.45%	5,942 $1.56 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $344,546 - $388,585	1,535 Added 240.6%	2,173 $490,000
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $98,282 - $109,371	-426 Reduced 40.04%	638 $155,000
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $146,691 - $162,279	669 Added 169.37%	1,064 $257,000
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $90,888 - $104,013	-457 Reduced 53.64%	395 $89,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $202,930 - $237,757	-956 Reduced 52.88%	852 $181,000
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $32,467 - $36,020	-139 Reduced 7.14%	1,808 $446,000
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $107,848 - $125,679	-486 Reduced 19.98%	1,947 $484,000
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $365,033 - $434,689	-1,687 Reduced 40.95%	2,433 $559,000
Q3 2020 Nov 04, 2020	SELL	$234.65 - $260.95 $32,616 - $36,272	-139 Reduced 3.26%	4,120 $1.05 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $12,066 - $14,807	-61 Reduced 1.41%	4,259 $1.09 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $45,013 - $59,699	-247 Reduced 5.41%	4,320 $875,000
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $400,801 - $480,243	2,302 Added 101.63%	4,567 $884,000
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $34,506 - $40,449	-207 Reduced 8.37%	2,265 $417,000
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $341,482 - $384,925	-1,888 Reduced 43.3%	2,472 $470,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $67,256 - $78,510	377 Added 9.47%	4,360 $849,000
Q3 2018 Oct 31, 2018	BUY	$185.29 - $208.89 $738,010 - $832,008	3,983 New	3,983 $826,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Fund Management Co., LTD with notifications on news.

Account

Harvest Fund Management Co., LTD Amgen Inc Transaction History